The meningitis vaccine project: the development, licensure, introduction, and impact of a new group a meningococcal conjugate vaccine for Africa.
Clinical Infectious Diseases, Volume 61, Issue suppl_5, November 2015.
https://academic.oup.com/cid/issue/61/suppl_5
Carr, J. P., MacLennan, J. M., Plested, E., Bratcher, H. B., Harrison, O. B., Aley, P. K., ... & Duale, K. (2022). Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme. Clinical Microbiology and Infection, 28(12), 1649-e1. https://doi.org/10.1016/j.cmi.2022.07.004
United Kingdom. The Green Book. (2022). Chapter 22: Meningococcal.
https://assets.publishing.service.gov.uk/media/628363d6e90e071f62029bb9/Meningococcal-greenbook-chapter-22_17May2022.pdf
Bwaka, A., Bita, A., Lingani, C., Fernandez, K., Durupt, A., Mwenda, J. M., ... & Preziosi, M. P. (2019). Status of the rollout of the meningococcal serogroup A conjugate vaccine in African meningitis belt countries in 2018. The Journal of Infectious Diseases, 220(Supplement_4), S140-S147.
https://doi.org/10.1093/infdis/jiz336
Soeters, H. M., Diallo, A. O., Bicaba, B. W., Kadadé, G., Dembélé, A. Y., Acyl, M. A., ... & MenAfriNet Consortium. (2019). Bacterial meningitis epidemiology in five countries in the meningitis belt of sub-Saharan Africa, 2015–2017. The Journal of infectious diseases, 220(Supplement_4), S165-S174.
https://doi.org/10.1093/infdis/jiz358
Topaz, N., Caugant, D. A., Taha, M. K., Brynildsrud, O. B., Debech, N., Hong, E., ... & Wang, X. (2019). Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011–2016. EBioMedicine, 41, 488-496.
https://doi.org/10.1016/j.ebiom.2019.02.054
Brynildsrud, O. B., Eldholm, V., Bohlin, J., Uadiale, K., Obaro, S., & Caugant, D. A. (2018). Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa. Proceedings of the National Academy of Sciences, 115(21), 5510-5515.
http://www.pnas.org/cgi/doi/10.1073/pnas.1802298115
LaForce, F. M., Djingarey, M., Viviani, S., & Preziosi, M. P. (2018). Lessons from the meningitis vaccine project. Viral Immunology, 31(2), 109-113.
https://doi.org/10.1089/vim.2017.0120
Yaesoubi, R., Trotter, C., Colijn, C., Yaesoubi, M., Colombini, A., Resch, S., ... & Cohen, T. (2018). The cost-effectiveness of alternative vaccination strategies for polyvalent meningococcal vaccines in Burkina Faso: A transmission dynamic modeling study. PLoS medicine, 15(1), e1002495.
https://doi.org/10.1371/journal.pmed.1002495
Trotter, C. L., Lingani, C., Fernandez, K., Cooper, L. V., Bita, A., Tevi-Benissan, C., ... & Stuart, J. M. (2017). Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data. The Lancet infectious diseases, 17(8), 867-872.
http://dx.doi.org/10.1016/S1473-3099(17)30301-8
Agnememel, A., Hong, E., Giorgini, D., Nuñez-Samudio, V., Deghmane, A. E., & Taha, M. K. (2016). Neisseria meningitidis serogroup X in sub-Saharan Africa. Emerging Infectious Diseases, 22(4), 698-702
http://dx.doi.org/10.3201/eid2204.150653
Gil-Cuesta J., Mukembe, N., Valentiner-Branth, P., Stefanoff, P., & Lenglet, A. D. (2015). Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14. PLoS Currents. 2015-02-02. https://doi.org/10.1371/currents.outbreaks
Tiffay, K., Jodar, L., Kieny, M. P., Socquet, M., & LaForce, F. M. (2015). The evolution of the meningitis vaccine project. Clinical Infectious Diseases, 61(suppl_5), S396-S403.
https://doi.org/10.1093/cid/civ594
Daugla, D. M., Gami, J. P., Gamougam, K., Naibei, N., Mbainadji, L., Narbé, M., ... & Greenwood, B. M. (2014). Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study. The Lancet, 383(9911), 40-47.
http://dx.doi.org/10.1016/S0140-6736(13)61612-8
Funk, A., Uadiale, K., Kamau, C., Caugant, D. A., Ango, U., & Greig, J. (2014). Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14. PLoS currents, 6, ecurrents-outbreaks.
https://doi.org/10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518
Kristiansen, P. A., Diomandé, F., Ba, A. K., Sanou, I., Ouédraogo, A. S., Ouédraogo, R., ... & Caugant, D. A. (2013). Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clinical infectious diseases, 56(3), 354-363.
https://doi.org/10.1093/cid/cis892
Novak, R. T., Kambou, J. L., Diomandé, F. V., Tarbangdo, T. F., Ouédraogo-Traoré, R., Sangaré, L., ... & Clark, T. A. (2012). Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. The Lancet infectious diseases, 12(10), 757-764.
https://doi.org/10.1016/S1473-3099(12)70168-8